179. ウィリアムズ症候群 Disease details / Clinical trials / Drug dev / DR info

臨床試験数 : 12 / 薬物数 : 21 - (DrugBank : 8) / 標的遺伝子数 : 9 - 標的パスウェイ数 : 35

薬物、開発者（Primary Sponsor）、臨床試験情報（症例登録開始年（Enrollment year）、フェーズ、ID、実施国）
Buspirone
   Massachusetts General Hospital
      2021   Phase 4   NCT04807517   United States
Clemastine
   Qilu Hospital of Shandong University
      2024   Phase 2   ChiCTR2500105345   China
Clemastine fumarate tablets
   Qilu Hospital of Shandong University
      2024   Phase 2   NCT06315699   China
Corn starch tablets
   Qilu Hospital of Shandong University
      2024   Phase 2   NCT06315699   China
Cozaar 50 MG comprimidos recubierto CON pelicula
   Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron
      2009   -   EUCTR2007-006059-37-ES   Spain
Lonoten
   Hospices Civils de Lyon
      2008   Phase 2   EUCTR2006-005745-11-FR   France
Losartan potasico
   Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron
      2009   -   EUCTR2007-006059-37-ES   Spain
Losartan potassium
   Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron
      2009   -   EUCTR2007-006059-37-ES   Spain
Methylphenidate, fluoxetin, risperidone
   The Chaim Sheba Medical Center
      2001   Phase 4   NCT00768820   Israel
Minoxidil
   Hospices Civils de Lyon
      2009   Phase 2   NCT00876200   France
      2008   Phase 2   EUCTR2006-005745-11-FR   France
ONE-time peripheral blood collection
   Qilu Hospital of Shandong University
      2026   -   NCT07537374   -
Open label clemastine with A blinded randomize withdrawal
   Sheba Medical Center
      2024   Phase 2   NCT06087757   Israel
Physical examination and urine and blood samples
   Hospices Civils de Lyon
      2019   -   NCT04051086   France
Vitamin D
   National Center for Research Resources (NCRR)
      1998   -   NCT00013962   United States